DETERMINATION OF ACTIVE INGREDIENT IN TAMSULOSIN DRUG BY USING HPLC
DOI:
https://doi.org/10.36103/ijas.v53i3.1564Keywords:
validation methods, stability-indicating, method development, acetonitrile.Abstract
This study was aimed to development and modification the method of analysis for active ingredient in Tamsulosin drug by using high performance liquid chromatography (HPLC) also determined shelf life and storage conditions for Tamsulosin. Chromatographic conditions utilized stationary phase C18 (250*4.6) mobile phase 0.05Nmixture of di hydrogen ortho phosphate and Acetonitrile 55:45 , preserve the flow rate near (1ml/min) and length of wave has been 275nm, The retention time found to be 10 minute for the HPLC process . The Tamsulosin assay result was found to be 99.93% . The calibration curve linearity analysis results showed a strong linear relationship in the concentration range (10-200ppm) and the correlation coefficient, slope and intercept value were 0.9933,11796,190017, respectively The percentage recovery was found 99%. LOD value was found to 0.00053 µg/ml and LOQ value was found to 0.0016 µg/ml , Precision was found to be 99.49% Robustness was found to 99.69%. Our proposed procedure confirmed a group of merits such as Linear ,accurate ,precise ,and robust , could be recommended for determination of Tamsulosin.
References
Al-Abedi G.J.K., and A.M.A. Amery. 2021. molecular diagnosis and phylogenetic analysis of babesia species isolated from ticks of infested cattle in wasit governorate Iraq. The Iraqi Journal of Agricultural.52(1) :136-145
Al-Ogaidi A. J. M. , B. Qasim, D. M. Hamid, and A. A. R. Mohammed. 2020. Ultra higher assessment of tyrosine compound by coupling for biological samples. Ann. Trop. Med. Public Heal. 23(19): 0–6
Al-Ogaidi A. J. M., A. M. Al-Gebori, K. F. Al-Azawi, and S. Khazaal. 2020. Ultra micro determination of ascorbic acid in biological samples by coupling reaction. AIP Conf. Proc. 2213(3): 1–7
Angelotti F. , C. R. S. Buffara, D. J. Tessamnn, R. A. Vieira, and J. B. Vida. 2014.Atividade protetora, curativa e erradicante de fungicidas no controle de ferrugem da videira .Cienc. Rural. 44(8): 1367–1370
Bajaj S. , D. Singla, and N. Sakhuja. 2012. Stability testing of pharmaceutical products.J. Appl. Pharm. Sci. 2(3): 129–138
Bari S. B. , Bakshi A. R., Jain P. S. and Surana S. J. 2011. Application of uv-spectroscopy and first order derivative method for determination of tamsulosin hydrochloride in bulk and Tablets. Pharm. Anal. Acta. 02(02) : 1-4
Bari S. B., A. R. Bakhshi, P. S. Jain, and S. J. Surana. 2011.Development and validation of stability-indicating hptlc determination of tamsulosin in bulk and pharmaceutical dosage form .Chromatogr. Res. Int. 10(4061): 1–6
Bird S. T. , J. A. C. Delaney, J. M. Brophy, M. Etminan, S. C. Skeldon, and A. G. Hartzema.2013. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: Risk window analyses using between and within patient methodology . BMJ. 347(5): 1–8
De Carvalho and M. J. R. 2013 .Extemporaneously Compounded Oral Medicines in European Hospital Pharmacies. Ph.D. Dissertation Submitted for the Degree of doctor of Philosophy Extemporaneously., University College London. pp. 1–438
Ganthi H. K. R., R. R. P, Y. J. Park, H. R. Bapatu, S. J. Park, and W. H. Cho. 2016. Stability indicating hplc method for quantification of solifenacin succinate and amp; tamsulosin hydrochloride along with its impurities in Tablet dosage form. Am. J. Anal. Chem. 07(11): 840–862
Hafeez Ahmed S. and et al. 2019. To develop new RP HPLC method for the simultaneous estimation of tamsulosin hydrochloride and dutasteride in pharmaceutical dosage form. J. Drug Dev. 2(1) :07–12
Kilmer P. D. 2010. Review Article: Review Article,” J. Theory, Pract. Crit. 11(3) : 369–373
Koteswari K. Gopi, P., M. Surendra, and P. Srikanth. 2018 . Development and in vitro characterization of tamsulosin hydrochloride pellets used for benign prostatic hyperplasia.J. pharm.chem. 8(4) :588–597
Kumar G. and Bs. Pavan Kumar. 2012 . Stability-indicating rp-hplc method for determination of tamsulosin hcl in pharmaceutical dosage form .J. Basic Clin. Pharm. 3(2): 255–260
Kumari R. , P. P. Dash, V. K. Lal, A. Mishra, and P. N. Murthy.2010. Rp-hplc method for the estimation of tamsulosin hydrochloride in Tablet dosage form. Indian J. Pharm. Sci.72(6): 785–787.
Mahmood S. Kh. A. A. Mhawesh and T. S. Abdullah 2019. comet assay for rapid detection of dna base damage in. The Iraqi Journal of Agricultural. 50(1):495-499
Mani S. and A. Arunachalam. 2013. Asian of pharmaceutical analysis . Asian J. Pharm. Anal. Med. Chem.1(12 ): pp. 184–195
Monir H. H., A. M. Ali, R. E. Refat, and S. S. Abbas .2020. Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in Presence of finasteride degradation product. Acta Chromatogr. 32 (2): 95–101
Mrudula D. V L N, G. Sai Prasad, P. V Rao, and S. Manohar Babu. 2014. simultaneous estimation and validation of tamsulosin and deutasteride in bulk and pharmaceutical dosage form. J. Pharm. 3(4) :242 – 248
Nanda R. K. , J. Gaikwad, and A. Prakash.2009. Estimation of tamsulosin and tolterodine in its pharmaceutical dosage form by spectrophotometric method. Int. J. PharmTech Res.1(3): 420–423
Patel D. and N. Patel. 2010.Validated rp-hplc and tlc methods for simultaneous estimation of tamsulosin hydrochloride and finasteride in combined dosage forms. Acta Pharm. 60((2): 197–205
Patel D. B. , N. J. Patel, S. K. Patel, and P. U. Patel. 2011. validated stability indicating hptlc method for the determination of dutasteride in pharmaceutical dosage forms. Chromatogr. Res. Int.2(1): 53–60
Rajesh S. C., K. Neelima, and P. Solairaj.2014.Method development and validation for the simultaneous estimation of dutasteride and tamsulosin hydrochloride in capsule dosage form by rp-hplc. Wo. J. Pharm. Res. 3(1): 535-547
Rana A. S. and S. L. Hari Kumar. 2013. Manufacturing Defects of Tablets - a Review . J. Drug Deliv. Ther. 3(6) : 200–206
Roy C. , J. Chakrabarty, and H. B. Patel. 2012.development and validation of a stability indicating binary rp-uplc method for determination of itraconazole in capsules dosage form. 2(3): 165–174
Rupapara V. V, Z. R. Dedania and R. Dedania.2021. Hplc method development and validation of deflazacort and tamsulosin hydrochloride in combined dosage form. Vijay al. World J. Pharm. Res.7(84):285–295
Salah M.I., Al Dabagh F.M.K. 2021. comparative analysis of some phenolic acids of in vitroand in vivogrown plant leaves of salvia hispanica.The Iraqi Journal of Agricultural Sciences.52(1):189-195
Sirisha P., G. Ashwini, V. Mohan Goud, J. Sharma, C. B. Praveena Devi, and L. Kumara Swamy. 2019.Method development and validation for estimation of tamsulosin in bulk and pharmaceutical dosage form by uplc. 9(2): 1–07
Thadanki M., P. K. Chadalawada, L. Pitta, D. Umashankar, and M. Latha Thadanki.2018. Formulation and in vitro evaluation of tamsulosin hcl sustained release pellets in capsules. Eur. J.Bio.Pharm. Sci. 5(1): 502-511
Thimmaraju M. K., V. Rao, and P. Siddartha Kumar .2011. RP HPLC method for the determination of tamsulosin in bulk and pharmaceutical formulations.J. appl. pharm. 01 (08): 177–180
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
2.jpg)
https://orcid.org/0000-0002-5774-5906 2.jpg)
